|drug3153||Sphenopalatine Ganglion Block with Placebo (Isotone NaCl) Wiki||1.00|
|drug3152||Sphenopalatine Ganglion Block with Local Anesthetic Wiki||1.00|
|drug2||"Sham"-block with Placebo (Isotone NaCl) Wiki||1.00|
|D013581||Synovial Cyst NIH||1.00|
|D045888||Ganglion Cysts NIH||0.58|
There is one clinical trial.
The outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which originated in Wuhan, China, has become a major concern all over the world. Convalescent plasma or immunoglobulins have been used as a last resort to improve the survival rate of patients with SARS whose condition continued to deteriorate despite treatment with pulsed methylprednisolone. Moreover, several studies showed a shorter hospital stay and lower mortality in patients treated with convalescent plasma than those who were not treated with convalescent plasma. Evidence shows that convalescent plasma from patients who have recovered from viral infections can be used effectively as a treatment of patients with active disease. To date, no specific treatment has been proven to be effective. The investigators plan to treat critical Covid-19 patients with hyperimmune plasma.
Description: death from any causeMeasure: Death Time: within 30 days
Description: days since intubationMeasure: time to extubation Time: within 7 days
Description: days from entry to exit from ICUMeasure: length of intensive care unit stay Time: within 7 days
Description: days from entry to exit from hospitalMeasure: length of hospitalization Time: within 30 days
Description: neutralizing titleMeasure: immune response Time: at days 1, 3 and 7
Description: naso-pharyngeal swab and BALMeasure: viral load Time: at days 1, 3 and 7
Data processed on January 01, 2021.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.Drug Reports MeSH Reports HPO Reports